Novo Nordisk
NVO
$86.75
Share price
2.10%
Change (1 day)
-50.64%
Change (1 year)
Categories
Novo Nordisk A / S produces and markets pharmaceutical products and services. Since its founding in Denmark in 1923, the company has developed into a leading company in the diabetes sector worldwide.
EPS for Novo Nordisk (NVO)
EPS in 2023 (TTM): $3.85
According to Novo Nordisk's latest financial reports the company's current EPS (TTM) is $3.96. In 2022 the company made an earnings per share (EPS) of $3.01 an increase over its 2021 EPS that were of $2.76.
EPS history for Novo Nordisk from 1996 to 2023
Annual EPS
| Year | EPS | Change |
|---|---|---|
| 2023 (TTM) | $3.85 | 28.09% |
| 2022 | $3.01 | 9.01% |
| 2021 | $2.76 | 15.08% |
| 2020 | $2.40 | 14.83% |
| 2019 | $2.09 | -1.68% |
| 2018 | $2.12 | 4.96% |
| 2017 | $2.02 | 31.08% |
| 2016 | $1.54 | -10.33% |
| 2015 | $1.72 | 13.91% |
| 2014 | $1.51 | 4.03% |
| 2013 | $1.45 | -28.81% |
| 2012 | $2.04 | 108.9% |
| 2011 | $0.98 | 25.59% |
| 2010 | $0.78 | 35.01% |
| 2009 | $0.58 | -9.17% |
| 2008 | $0.63 | 61.35% |
| 2007 | $0.39 | 28.96% |
| 2006 | $0.30 | 25.63% |
| 2005 | $0.24 | 4.17% |
| 2004 | $0.23 | 13.55% |
| 2003 | $0.21 | 36.87% |
| 2002 | $0.15 | -6.99% |
| 2001 | $0.16 | 21.56% |
| 2000 | $0.13 | 49.45% |
| 1999 | $0.08870 | 3.78% |
| 1998 | $0.08547 | 12.15% |
| 1997 | $0.07621 | 24.74% |
| 1996 | $0.06109 |
EPS for similar companies or competitors
| Company | EPS | EPS differencediff. | Country |
|---|---|---|---|
 | $2.58 | -34.87% | 🇺🇸 USA |
 | $7.53 | 90.12% | 🇺🇸 USA |
 | $5.50 | 39.02% | 🇺🇸 USA |
 | $4.41 | 11.36% | 🇫🇷 France |